Evaluating the utility of intralipid infusion to improve live birth rates in patients with recurrent pregnancy loss or recurrent implantation failure

• Auteurs principaux: Anne E Martini (Auteur), Sue Jasulaitis (Auteur), Louis F Fogg (Auteur), Meike L Uhler (Auteur), Jennifer E Hirshfeld-Cytron (Auteur)
• Format: Livre
• Publié: Wolters Kluwer Medknow Publications, 2018-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Context: Intralipid is used to improve clinical outcomes in patients with recurrent pregnancy loss (RPL) or recurrent implantation failure (RIF) with elevated natural killer (NK) cells. Data supporting this practice is conflicting but suggestive of minimal benefit. Aims: The aims of this study are t...